Via the lead plaintiffs/plaintiffs' steering committee firm's website, then (as of mid-April 2015):
. . . .Plaintiffs Steering Committee ("PSC") Lead Counsel Tim O’Brien announces that numerous settlement funds release applications have been received and approved by Merck and forwarded to the Escrow Agent. The Escrow Agent informed the PSC that it will begin wire disbursements on a twice-monthly basis for those settlement funds release applications approved by Merck. For each such disbursement, the Escrow Agent will email an escrow disbursement instruction form to the claimant’s counsel who will then indicate wire instructions which will then be returned to the Escrow Agents as all disbursements will occur by wire transfer. . . .
Here's to wishing a safe and serene Mother's Day, to one and all.
And to answer my anonymous commenter below, there is no analogous website, that tracks the Propecia® MDL, in the way the linked one above does (that is, no single plaintiffs' firm of which I am aware runs one). So -- mine is just a review of the electronic federal case file, in the Eastern District of New York -- Propecia MDL, on PACER.
No comments:
Post a Comment